Skip to main content
Top
Published in: BMC Geriatrics 1/2021

Open Access 01-12-2021 | Sarcopenia | Research article

Associations of sarcopenia and its defining components with cognitive function in community-dwelling oldest old

Authors: Anying Bai, Weihao Xu, Jing Sun, Juan Liu, Xinli Deng, Linna Wu, Xiao Zou, Jing Zuo, Lin Zou, Yunxia Liu, Hengge Xie, Xiaohong Zhang, Li Fan, Yixin Hu

Published in: BMC Geriatrics | Issue 1/2021

Login to get access

Abstract

Background

This study aimed to investigate the associations of sarcopenia and its defining components with cognitive function in community-dwelling oldest old (over 80 years old) in China.

Methods

Sarcopenia was diagnosed by the 2019 Asian Working Group for Sarcopenia (AWGS) criteria. Cognitive function was evaluated by the Montreal Cognitive Assessment (MoCA). Logistic and linear regression models were used to explore the associations of sarcopenia and its defining components with risk of mild cognitive impairment (MCI), and performance on multiple cognitive domains among 428 adults aged 80 years and older.

Results

The overall prevalence of sarcopenia was 35.5%, with 40.34% for men and 32.14% for women. The prevalence of MCI was higher among sarcopenic oldest old than non-sarcopenic oldest old (28.95% vs. 17.39%, p = 0.005). Multivariate logistic regression analyses showed that sarcopenia [odds ratio (OR) = 1.86, 95% confidence interval (CI): 1.04–3.33], low handgrip strength (HS) [OR = 2.33, 95% CI: 1.40–3.87] and slow gait speed (GS) [OR = 2.31, 95% CI: 1.13–4.72] were significantly and independently associated with risk of MCI. Multivariate linear regression analyses showed that low HS was associated with worse performance in global cognitive function, visuospatial and executive function, naming and delayed recall.

Conclusions

Sarcopenia, low HS and low GS was significantly associated with MCI in community-dwelling oldest old. The associations between sarcopenia and its defining components with different cognitive subdomains could be further explored in the future.
Literature
3.
go back to reference Cawthon PM, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Establishing the link between lean mass and grip strength cut points with mobility disability and other health outcomes: proceedings of the sarcopenia definition and outcomes consortium conference. J Gerontol A Biol Sci Med Sci. 2020;75(7):1317–23. https://doi.org/10.1093/gerona/glz081.CrossRefPubMed Cawthon PM, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Establishing the link between lean mass and grip strength cut points with mobility disability and other health outcomes: proceedings of the sarcopenia definition and outcomes consortium conference. J Gerontol A Biol Sci Med Sci. 2020;75(7):1317–23. https://​doi.​org/​10.​1093/​gerona/​glz081.CrossRefPubMed
8.
go back to reference Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet (London, Engl). 2015;386(9990):266–73.CrossRef Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet (London, Engl). 2015;386(9990):266–73.CrossRef
15.
go back to reference McGrath R, Vincent BM, Hackney KJ, Robinson-Lane SG, Downer B, Clark BC. The Longitudinal Associations of Handgrip Strength and Cognitive Function in Aging Americans. J Am Med Dir Assoc. 2020;21(5):634–9 e631.CrossRef McGrath R, Vincent BM, Hackney KJ, Robinson-Lane SG, Downer B, Clark BC. The Longitudinal Associations of Handgrip Strength and Cognitive Function in Aging Americans. J Am Med Dir Assoc. 2020;21(5):634–9 e631.CrossRef
18.
go back to reference van Kan GA, Cesari M, Gillette-Guyonnet S, Dupuy C, Vellas B, Rolland Y. Association of a 7-year percent change in fat mass and muscle mass with subsequent cognitive dysfunction: the EPIDOS-Toulouse cohort. J Cachexia Sarcopenia Muscle. 2013;4(3):225–9.CrossRef van Kan GA, Cesari M, Gillette-Guyonnet S, Dupuy C, Vellas B, Rolland Y. Association of a 7-year percent change in fat mass and muscle mass with subsequent cognitive dysfunction: the EPIDOS-Toulouse cohort. J Cachexia Sarcopenia Muscle. 2013;4(3):225–9.CrossRef
19.
go back to reference Xu X, Chong E, Hilal S, Ikram MK, Venketasubramanian N, Chen C. Beyond Screening: Can the Mini-Mental State Examination be Used as an Exclusion Tool in a Memory Clinic? Diagnostics (Basel, Switzerland). 2015;5(4):475–86. Xu X, Chong E, Hilal S, Ikram MK, Venketasubramanian N, Chen C. Beyond Screening: Can the Mini-Mental State Examination be Used as an Exclusion Tool in a Memory Clinic? Diagnostics (Basel, Switzerland). 2015;5(4):475–86.
20.
go back to reference Spering CC, Hobson V, Lucas JA, Menon CV, Hall JR, O’Bryant SE. Diagnostic accuracy of the MMSE in detecting probable and possible Alzheimer's disease in ethnically diverse highly educated individuals: an analysis of the NACC database. J Gerontol Series A. 2012;67(8):890–6. https://doi.org/10.1093/gerona/gls006.CrossRef Spering CC, Hobson V, Lucas JA, Menon CV, Hall JR, O’Bryant SE. Diagnostic accuracy of the MMSE in detecting probable and possible Alzheimer's disease in ethnically diverse highly educated individuals: an analysis of the NACC database. J Gerontol Series A. 2012;67(8):890–6. https://​doi.​org/​10.​1093/​gerona/​gls006.CrossRef
23.
go back to reference Gillis C, Mirzaei F, Potashman M, Ikram MA, Maserejian N. The incidence of mild cognitive impairment: A systematic review and data synthesis. Alzheimer's Dementia (Amsterdam, Netherlands). 2019;11:248–56.CrossRef Gillis C, Mirzaei F, Potashman M, Ikram MA, Maserejian N. The incidence of mild cognitive impairment: A systematic review and data synthesis. Alzheimer's Dementia (Amsterdam, Netherlands). 2019;11:248–56.CrossRef
26.
go back to reference Zeng Y, Feng Q, Hesketh T, Christensen K, Vaupel JW. Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study. Lancet (London, England). 2017;389(10079):1619–29.CrossRef Zeng Y, Feng Q, Hesketh T, Christensen K, Vaupel JW. Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study. Lancet (London, England). 2017;389(10079):1619–29.CrossRef
30.
go back to reference Du YF, Lv PY, Ji Y, Wu LY, Shi L. 2018 Chinese guidelines for the diagnosis and treatment of dementia and cognitive impairment (5): diagnosis and treatment of mild cognitive impairment. Chin Med J. 2018;(17):1294-301. doi:CNKI:SUN:ZHYX.0.2018-17-004. Du YF, Lv PY, Ji Y, Wu LY, Shi L. 2018 Chinese guidelines for the diagnosis and treatment of dementia and cognitive impairment (5): diagnosis and treatment of mild cognitive impairment. Chin Med J. 2018;(17):1294-301. doi:CNKI:SUN:ZHYX.0.2018-17-004.
31.
go back to reference Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology. Neurology. 2018;90(3):126–35.CrossRef Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology. Neurology. 2018;90(3):126–35.CrossRef
32.
go back to reference Meng XM, Yu FC, Yin J, Tang XM, Chen XP, Liu YZ, et al. A preliminary study of Montreal cognitive assessment scale in patients with mild cognitive impairment. Chin J Geriatr Cardio Cerebrovasc Dis. 2012;14(11):1173–5. Meng XM, Yu FC, Yin J, Tang XM, Chen XP, Liu YZ, et al. A preliminary study of Montreal cognitive assessment scale in patients with mild cognitive impairment. Chin J Geriatr Cardio Cerebrovasc Dis. 2012;14(11):1173–5.
34.
go back to reference Ali A, Rahut DB. Healthy foods as proxy for functional foods: Consumers' awareness, perception, and demand for natural functional foods in Pakistan. Int J Food Sci. 2019:6390650. Ali A, Rahut DB. Healthy foods as proxy for functional foods: Consumers' awareness, perception, and demand for natural functional foods in Pakistan. Int J Food Sci. 2019:6390650.
39.
go back to reference Abellan van Kan G, Cesari M, Gillette-Guyonnet S, Dupuy C, Nourhashémi F, Schott AM, et al. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing. 2013;42(2):196–202.CrossRef Abellan van Kan G, Cesari M, Gillette-Guyonnet S, Dupuy C, Nourhashémi F, Schott AM, et al. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing. 2013;42(2):196–202.CrossRef
40.
go back to reference Nishiguchi S, Yamada M, Shirooka H, Nozaki Y, Fukutani N, Tashiro Y, et al. Sarcopenia as a Risk Factor for Cognitive Deterioration in Community-Dwelling Older Adults: A 1-Year Prospective Study. J Am Med Dir Assoc. 2016;17(4):372 e375–378.CrossRef Nishiguchi S, Yamada M, Shirooka H, Nozaki Y, Fukutani N, Tashiro Y, et al. Sarcopenia as a Risk Factor for Cognitive Deterioration in Community-Dwelling Older Adults: A 1-Year Prospective Study. J Am Med Dir Assoc. 2016;17(4):372 e375–378.CrossRef
41.
go back to reference Lee I, Cho J, Hong H, Jin Y, Kim D, Kang H. Sarcopenia is associated with cognitive impairment and depression in elderly Korean women. Iran J Public Health. 2018;47(3):327–34.PubMedPubMedCentral Lee I, Cho J, Hong H, Jin Y, Kim D, Kang H. Sarcopenia is associated with cognitive impairment and depression in elderly Korean women. Iran J Public Health. 2018;47(3):327–34.PubMedPubMedCentral
42.
go back to reference Wood JL, Weintraub S, Coventry C, Xu J, Zhang H, Rogalski E, et al. Montreal cognitive assessment (MoCA) performance and domain-specific index scores in amnestic versus aphasic dementia. J Int Neuropsychol Soc. 2020:1–5. Wood JL, Weintraub S, Coventry C, Xu J, Zhang H, Rogalski E, et al. Montreal cognitive assessment (MoCA) performance and domain-specific index scores in amnestic versus aphasic dementia. J Int Neuropsychol Soc. 2020:1–5.
55.
go back to reference Chang KV, Hsu TH, Wu WT, Huang KC, Han DS: Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc 2016, 17; (12): 1164.e1167–1164.e1115. Chang KV, Hsu TH, Wu WT, Huang KC, Han DS: Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc 2016, 17; (12): 1164.e1167–1164.e1115.
64.
go back to reference Chen LK, Hwang AC, Lee WJ, Peng LN, Lin MH, Neil DL, Shih SF, Loh CH, Chiou ST. Efficacy of multidomain interventions to improve physical frailty, depression and cognition: data from cluster-randomized controlled trials. J Cachexia Sarcopenia Muscle. 2020;11(3):650–62. https://doi.org/10.1002/jcsm.12534. Epub 2020 Mar 5. Chen LK, Hwang AC, Lee WJ, Peng LN, Lin MH, Neil DL, Shih SF, Loh CH, Chiou ST. Efficacy of multidomain interventions to improve physical frailty, depression and cognition: data from cluster-randomized controlled trials. J Cachexia Sarcopenia Muscle. 2020;11(3):650–62. https://​doi.​org/​10.​1002/​jcsm.​12534. Epub 2020 Mar 5.
Metadata
Title
Associations of sarcopenia and its defining components with cognitive function in community-dwelling oldest old
Authors
Anying Bai
Weihao Xu
Jing Sun
Juan Liu
Xinli Deng
Linna Wu
Xiao Zou
Jing Zuo
Lin Zou
Yunxia Liu
Hengge Xie
Xiaohong Zhang
Li Fan
Yixin Hu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2021
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-021-02190-1

Other articles of this Issue 1/2021

BMC Geriatrics 1/2021 Go to the issue